These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 11426837

  • 1. Delta9-tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo: a microdialysis study.
    Acquas E, Pisanu A, Marrocu P, Goldberg SR, Di Chiara G.
    Eur J Pharmacol; 2001 May 11; 419(2-3):155-61. PubMed ID: 11426837
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A.
    Gessa GL, Mascia MS, Casu MA, Carta G.
    Eur J Pharmacol; 1997 May 26; 327(1):R1-2. PubMed ID: 9185841
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices.
    Gifford AN, Samiian L, Gatley SJ, Ashby CR.
    Eur J Pharmacol; 1997 Apr 18; 324(2-3):187-92. PubMed ID: 9145770
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors.
    Hough LB, Nalwalk JW, Stadel R, Timmerman H, Leurs R, Paria BC, Wang X, Dey SK.
    J Pharmacol Exp Ther; 2002 Oct 18; 303(1):314-22. PubMed ID: 12235266
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors.
    Petitet F, Jeantaud B, Reibaud M, Imperato A, Dubroeucq MC.
    Life Sci; 1998 Oct 18; 63(1):PL1-6. PubMed ID: 9667767
    [Abstract] [Full Text] [Related]

  • 15. Potentiation of penile erection and yawning responses to apomorphine by cannabinoid receptor antagonist in rats.
    da Silva GE, Fernandes MS, Takahashi RN.
    Neurosci Lett; 2003 Sep 25; 349(1):49-52. PubMed ID: 12946584
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
    Craft RM, Wakley AA, Tsutsui KT, Laggart JD.
    J Pharmacol Exp Ther; 2012 Mar 25; 340(3):787-800. PubMed ID: 22182934
    [Abstract] [Full Text] [Related]

  • 19. Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A.
    Aceto MD, Scates SM, Lowe JA, Martin BR.
    Eur J Pharmacol; 1995 Aug 25; 282(1-3):R1-2. PubMed ID: 7498260
    [Abstract] [Full Text] [Related]

  • 20. Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus.
    Maneuf YP, Nash JE, Crossman AR, Brotchie JM.
    Eur J Pharmacol; 1996 Jul 18; 308(2):161-4. PubMed ID: 8840127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.